Amneal Pharmaceuticals earnings were -$174.6M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest AMRX earnings report on Jun 30, 2024 announced Q2 2024 earnings of $6.0M, down 106.5% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, AMRX reported annual earnings of -$84.0M, with -35.4% growth. The next AMRX earnings date is Nov 4, 2024.
Amneal Pharmaceuticals Earnings Reports & History FAQ
What were Amneal Pharmaceuticals's earnings last quarter?
On AMRX's earnings call on Invalid Date, Amneal Pharmaceuticals (NASDAQ: AMRX) reported Q2 2024 earnings per share (EPS) of $0.02, up 75% year over year. Total AMRX earnings for the quarter were $5.99 million. In the same quarter last year, Amneal Pharmaceuticals's earnings per share (EPS) was $0.08.
The next AMRX earnings date is Invalid Date. Add AMRX to your watchlist to be reminded of Amneal Pharmaceuticals's next earnings date.
What was AMRX's earnings growth in the past year?
As of Amneal Pharmaceuticals's earnings date in Invalid Date, Amneal Pharmaceuticals's earnings has grown year over year. AMRX earnings in the past year totalled -$174.62 million.
Is Amneal Pharmaceuticals profitable or losing money?
As of the last Amneal Pharmaceuticals earnings report, Amneal Pharmaceuticals is currently losing money. Amneal Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$174.62 million, a 8,426.17% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.